eMedicine Specialties > Allergy and Immunology > Major Allergic Diseases

Food Allergies

Author: Dan Atkins, MD, Assistant Professor, Department of Pediatrics, Division of Ambulatory Pediatrics, Department of Pediatrics, Director, University of Colorado Health Sciences Center; Head, Pediatric Day Program, National Jewish Medical and Research Center
Coauthor(s): John M James, MD, Department of Allergy and Immunology, Department of Pediatrics, Consulting Staff, Colorado Allergy and Asthma Centers, PC
Contributor Information and Disclosures

Updated: Jun 13, 2006

Introduction

Background

Adverse food reactions can be broadly classified into 2 categories. The first category consists of immunologically-mediated adverse reactions to foods; these reactions are unrelated to any physiologic effect of the food or food additive. These reactions include disorders mediated by immunoglobulin E (IgE) antibodies (eg, IgE-mediated reaction to peanuts), which begin during or soon after exposure to the food, and others resulting from non–IgE-mediated mechanisms (eg, non–IgE-mediated reactions such as protein-induced enterocolitis syndrome), which generally take several hours to evolve.  

The second category is food intolerance. These reactions include any adverse physiologic response to a food or food additive that is not immunologically mediated (eg, lactose intolerance, bacterial food poisoning).

Pathophysiology

Allergic reactions to food are IgE-mediated or non–IgE-mediated. Immune responses mediated by specific IgE antibodies are the most widely recognized mechanism of food hypersensitivity. Patients with atopy produce IgE antibodies to specific epitopes of the food allergen. These antibodies bind to high-affinity IgE receptors on circulating basophils and tissue mast cells present in the skin, gastrointestinal tract, and respiratory tract. Subsequent allergen exposure binds two adjacent IgE antibodies, resulting in receptor cross-linking and intracellular signaling that initiates the release of numerous mediators, including histamine, prostaglandins, leukotrienes, chemotactic factors, and cytokines. The effects of these mediators on surrounding tissues result in vasodilatation, smooth muscle contraction, and mucus secretion, which, in turn, are responsible for the spectrum of clinical symptoms observed during allergic reactions to food.

Food allergens are typically water-soluble glycoproteins resistant to heating and proteolysis with molecular weights of 10-70 kd. These characteristics facilitate the absorption of these allergens across mucosal surfaces. Numerous food allergens are purified and well-characterized, such as peanut Ara h1, Ara h2, and Ara h3; chicken egg white Gal d1, Gal d2, and Gal d3; soybean-Gly m1; fish-Gad c1; and shrimp-Pen a1. Closely related foods frequently contain allergens that cross-react immunologically (ie, lead to the generation of specific IgE antibodies detectable by skin prick or in vitro testing) but less frequently cross-react clinically. Finally, cross-reactive allergens have been identified among certain foods and airborne pollens (see Pollen-food allergy syndrome). Conserved homologous proteins shared by pollens and foods likely account for this cross-reactivity.

Frequency

United States

General surveys report that as many as 25-30% of households consider at least 1 family member to have a food allergy. This high rate is not supported by controlled studies in which food challenges are used to confirm patient histories. The actual prevalence of food allergies is estimated to be approximately 6% in infants and children and 3.7 % in adults. Several published prospective investigations have determined the prevalence of certain common food allergies in children (eg, cow milk, 2.5%; eggs, 1.3%; peanuts, 0.8%; wheat, 0.4%; soy, 0.4%).

International

Prospective studies from several different countries indicate that approximately 2.5% of newborn infants experience hypersensitivity reactions to cow milk in the first year of life. A hypersensitivity reaction to peanuts occurs in approximately 0.5% of children in the United Kingdom. Surveys from the United Kingdom indicate that 1.4-1.8% of adults experience adverse food reactions and 0.01-0.23% of adults are affected by adverse reactions to food additives. Studies from the Netherlands demonstrate that approximately 2% of the adult Dutch population is affected.

Mortality/Morbidity

  • Severe anaphylactic reactions, including death, can occur following the ingestion of food. Typical symptoms observed in a food-induced anaphylactic reaction involve the skin, gastrointestinal tract, and respiratory tract. Frequently observed symptoms include oropharyngeal pruritus, angioedema (eg, laryngeal edema), stridor, dysphonia, cough, dyspnea, wheezing, nausea, vomiting, diarrhea, flushing, urticaria, and angioedema. Fatalities result from severe laryngeal edema, irreversible bronchospasm, refractory hypotension, or a combination thereof. Food allergy has been confirmed in approximately one third of the patients with anaphylaxis presenting to the emergency department at the Mayo Clinic.
  • Peanuts, tree nuts, and shellfish are the foods most often implicated in severe food-induced anaphylactic reactions, although anaphylactic reactions have been reported to a wide variety of foods.
  • Risk factors for fatal food-induced anaphylaxis include (1) the presence of asthma, especially in patients with poorly controlled disease; (2) previous episodes of anaphylaxis with the incriminated food; (3) a failure to recognize early symptoms of anaphylaxis; and (4) a delay or lack of immediate use of emergency medications (eg, epinephrine, antihistamines) to treat the allergic reaction.

Race

  • No predilection is known.

Sex

  • No predilection is known.

Age

  • In infants and children younger than 3 years, the prevalence of food allergy is approximately 6%.
  • The estimated prevalence in adults is approximately 3.7%.

Clinical

History

  • Necessary elements of a thorough medical history

    • Develop a complete list of all foods suspected to cause symptoms.
    • Discuss the manner of preparation of the food (cooked, raw, added spices or other ingredients).
    • Determine the minimum quantity of food exposure required to cause the symptoms.
    • Determine the reproducibility of symptoms upon exposure to the food.
    • Obtain a thorough description of each reaction, including the following:

      • The route of exposure (ingestion, skin contact, inhalation, injection) and dose
      • The timing of the onset of symptoms in relation to food exposure
      • All observed symptoms and each one’s severity
      • The duration of the reaction
      • The treatment provided and the clinical response to treatment
      • The most recent reaction
         
    • Inquire about a personal or family history of other allergic disease.
       
  • Cutaneous reactions

    • These are the most common clinical manifestations of an allergic reaction to a food or food additive.
    • Symptoms range from acute urticaria (most common) to flushing to angioedema to exacerbations of atopic dermatitis.
    • Food allergy is rarely the cause of chronic urticaria or angioedema.
       
  • Atopic dermatitis

    • Significant controversy surrounds the role of food allergy in the pathogenesis of atopic dermatitis. Studies show that of patients with moderate chronic atopic dermatitis, 35-40% have IgE-mediated food allergy contributing to their skin disease.
    • Both food-specific IgE-mediated and cellular mechanisms appear responsible for chronic eczematous inflammation.
    • Removal of a specific food allergen leads to reduction or resolution of clinical symptoms in affected patients; reintroduction of the food exacerbates the atopic dermatitis. Reintroduction of a suspected food allergen should be performed under medical supervision because, in some instances, initial reintroduction of the food after a period of dietary elimination has resulted in more significant symptoms than were observed when the food was regularly ingested.
    • Prophylactic studies show that avoiding particular foods (eg, cow milk, eggs, peanuts) helps delay the onset of atopic dermatitis.
       
  • Dermatitis herpetiformis

    • This is an unusual form of non-IgE cell-mediated hypersensitivity related to celiac disease. It manifests clinically with a chronic and intensely pruritic rash with a symmetrical distribution that has some similarities to the typical rash distribution of atopic dermatitis.
    • Elimination of gluten from the diet usually leads to resolution of skin symptoms.
       
  • IgE-mediated gastrointestinal food allergy

    • These food allergy reactions include immediate hypersensitivity reactions and the pollen-food allergy syndrome (oral allergy syndrome).
    • Specific gastrointestinal symptoms include nausea, vomiting, abdominal pain, and cramping. Diarrhea is found less frequently.
       
  • Pollen-food allergy syndrome (Oral allergy syndrome)

    • Patients with this syndrome develop itching or tingling of the lips, tongue, palate, and throat following the ingestion of certain foods. In addition, edema of the lips, tongue, and uvula and a sensation of tightness in the throat may be observed. In fewer than 3% of cases, symptoms progress to more systemic reactions, such as laryngeal edema or hypotension.
    • This syndrome is caused by cross-reactivity between certain pollen and food allergens. For example, individuals with ragweed allergy may experience oropharyngeal symptoms following the ingestion of bananas or melons, and patients with birch pollen allergy may experience these symptoms following the ingestion of raw carrots, celery, potato, apple, hazelnut, or kiwi.
       
  • Mixed IgE/non-IgE gastrointestinal food allergy (eosinophilic gastroenteritis)

    • Typical symptoms include postprandial nausea, abdominal pain, and a sensation of early satiety.
    • One of the hallmarks in children is weight loss or failure to thrive.
    • CBC count and differential findings may show eosinophilia in approximately 50% of patients; however, this is not diagnostic. Typically, endoscopy and biopsy must be performed in order to establish the presence of eosinophils in the intestinal wall. While a dense eosinophil infiltrate may be seen anywhere from the lower esophagus throughout the large bowel, involvement is patchy and variable.
    • Ultimately, an elemental or oligoantigenic diet is necessary to aid in the diagnosis.
    • If the patient does not respond to the elemental diet, a trial of systemic oral corticosteroids can be useful for resolving the clinical symptoms.
       
  • Non–IgE-mediated gastrointestinal food allergy

    • Dietary protein enterocolitis is a syndrome that typically manifests in the first few months of life in a child who has severe projectile vomiting, diarrhea, and failure to thrive.
    • Cow milk and soy protein formulas are usually responsible for these reactions, which occur 2 or more hours after food ingestion.
    • Infants typically appear lethargic, wasted, and dehydrated. To establish the diagnosis, an oral challenge study must be performed.
       
  • Upper and lower respiratory tract reactions

    • Upper respiratory reactions typically include nasal congestion, sneezing, nasal pruritus, or rhinorrhea. They are usually observed in conjunction with ocular, skin, or gastrointestinal symptoms.
    • IgE-mediated pulmonary symptoms may include laryngeal edema, cough, or bronchospasm.
       
  • Asthma

    • The role of food allergy in the pathogenesis of asthma is a controversial area of investigation.
    • At the National Jewish Center for Immunology and Respiratory Medicine, 67 of the 279 children (24%) with a history of food-induced asthma were documented to have a positive result after a blinded food challenge, which included wheezing. Interestingly, only 5 (2%) of these patients had wheezing as their only objective adverse symptom.
    • In a related report, 320 children with atopic dermatitis undergoing blinded food challenges at Johns Hopkins Hospital were monitored for respiratory reactions. Overall, 34 of 205 (17%) children with positive results from food challenges developed wheezing as part of their reaction. Therefore, a conservative estimate is that 5-10% of patients with asthma have food-induced allergy symptoms.
    • In a pediatric case-controlled study comparing 19 children who required ventilation for an exacerbation of asthma and 38 control subjects matched by sex, age, and ethnicity, coincident food allergy was found to be independently associated with life-threatening asthma.
    • Wheezing as the only manifestation of an allergic reaction to food is rare.
    • Children with atopic dermatitis, especially those with food reactions confirmed during blinded food challenges, appear to have a higher risk for developing food-induced asthma.
    • The primary clinical effect is not acute bronchopulmonary obstruction, but chronic asthma symptoms or difficulty in controlling the asthma.
       
  • Food-induced pulmonary hemosiderosis (Heiner syndrome)

    • This is a rare disorder characterized by recurrent episodes of pneumonia associated with pulmonary infiltrates, hemosiderosis, gastrointestinal blood loss, iron deficiency anemia, and failure to thrive in infants.
    • While the precise immunologic mechanism is unknown, it is thought to be secondary to a non-IgE hypersensitivity process.
       
  • Food-induced anaphylaxis

    • Following the ingestion of food, severe anaphylactic reactions (ie, systemic allergic reactions), including death, can occur.
    • Symptoms may include the following:

      • Oropharyngeal pruritus
      • Angioedema (eg, laryngeal edema)
      • Urticaria
      • Ocular injection, ocular pruritus, conjunctival edema, periocular swelling
      • Nasal congestion, nasal pruritus, rhinorrhea, and sneezing
      • Stridor
      • Dysphonia
      • Cough
      • Dyspnea
      • Wheezing, bronchospasm
      • Nausea
      • Emesis
      • Abdominal pain
      • Diarrhea
      • A feeling of impending doom
      • Cardiovascular collapse
         
    • Risk factors for fatal reactions include the following:

      • The presence of asthma, especially in patients with poorly controlled disease
      • Previous episodes of anaphylaxis with the incriminated food
      • Failure to recognize early symptoms of anaphylaxis
      • Delay or lack of immediate use of emergency medications (eg, epinephrine, antihistamines)

Physical

  • The physical examination findings are most useful for assessing overall nutritional status, growth parameters, and signs of other allergic disease, such as atopic dermatitis, allergic rhinitis, or asthma.
  • Findings from a comprehensive physical examination can help rule out other conditions that may mimic food allergy.

Causes

  • Any food protein can trigger an allergic response, and allergic reactions to a large number of foods have been documented; however, only a small group of foods account for most of these reactions.
  • Eggs, milk, peanuts, soy, fish, shellfish, tree nuts, and wheat are the foods most often implicated in allergic reactions that have been confirmed in well-controlled blinded food challenges.
  • Investigations of near-fatal or fatal anaphylactic reactions following food ingestion reveal that most are caused by peanuts, tree nuts, and shellfish.

More on Food Allergies

Overview: Food Allergies
Differential Diagnoses & Workup: Food Allergies
Treatment & Medication: Food Allergies
Follow-up: Food Allergies
References

References

  1. Altman DR, Chiaramonte LT. Public perception of food allergy. J Allergy Clin Immunol. Jun 1996;97(6):1247-51. [Medline].

  2. American Academy of Allergy and Immunology. Personnel and equipment to treat systemic reactions caused by immunotherapy with allergenic extracts. American Academy of Allergy and Immunology. J Allergy Clin Immunol. Feb 1986;77(2):271-3. [Medline].

  3. Bacharier LB. Are the results of oral food challenges predictable?. Ann Allergy Asthma Immunol. Feb 2004;92(2):195-7. [Medline].

  4. Barnes-Koerner C, Sampson HA. Diets and nutrition in food allergy. In: Metcalfe DD, Sampson HA, Simon RA, eds. Food Allergy: Adverse Reactions to Foods and Food Additives. 2nd ed. Cambridge, Mass: Blackwell Scientific; 1997:. 461-84.

  5. Bernhisel-Broadbent J. Allergenic cross-reactivity of foods and characterization of food allergens and extracts. Ann Allergy Asthma Immunol. Oct 1995;75(4):295-303; quiz 304-7. [Medline].

  6. Bernhisel-Broadbent J, Scanlon SM, Sampson HA. Fish hypersensitivity. I. In vitro and oral challenge results in fish- allergic patients. J Allergy Clin Immunol. Mar 1992;89(3):730-7. [Medline].

  7. Bernhisel-Broadbent J, Taylor S, Sampson HA. Cross-allergenicity in the legume botanical family in children with food hypersensitivity. II. Laboratory correlates. J Allergy Clin Immunol. Nov 1989;84(5 Pt 1):701-9. [Medline].

  8. Bock SA. Prospective appraisal of complaints of adverse reactions to foods in children during the first 3 years of life. Pediatrics. May 1987;79(5):683-8. [Medline].

  9. Bock SA. Respiratory reactions induced by food challenges in children with pulmonary disease. Pediatr Allergy Immunol. 1992;3:82.

  10. Bock SA. The natural history of food sensitivity. J Allergy Clin Immunol. Feb 1982;69(2):173-7. [Medline].

  11. Bock SA, Atkins FM. Patterns of food hypersensitivity during sixteen years of double-blind, placebo-controlled food challenges. J Pediatr. Oct 1990;117(4):561-7. [Medline].

  12. Bock SA, Lee WY, Remigio L, et al. Appraisal of skin tests with food extracts for diagnosis of food hypersensitivity. Clin Allergy. Nov 1978;8(6):559-64. [Medline].

  13. Bock SA, Sampson HA, Atkins FM, et al. Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: a manual. J Allergy Clin Immunol. Dec 1988;82(6):986-97. [Medline].

  14. Burks AW, James JM, Hiegel A, et al. Atopic dermatitis and food hypersensitivity reactions. J Pediatr. Jan 1998;132(1):132-6. [Medline].

  15. Condemni JJ. Unproved diagnostic and therapeutic techniques. In: Metcalfe DD, Sampson HA, Simon RA, eds. Food Allergy: Adverse Reactions to Foods and Food Additives. 2nd ed. Cambridge, Mass: Blackwell Scientific; 1997:. 541.

  16. David TJ, Waddington E, Stanton RH. Nutritional hazards of elimination diets in children with atopic eczema. Arch Dis Child. Apr 1984;59(4):323-5. [Medline].

  17. Eigenmann PA, Sampson HA. Interpreting skin prick tests in the evaluation of food allergy in children. Pediatr Allergy Immunol. Nov 1998;9(4):186-91. [Medline].

  18. Hawrylowicz CM, Jarman ER, Guida L, et al. T-cell receptor peptides that inhibit the T-cell response to allergen induce transforming growth factor-beta 1 production. J Allergy Clin Immunol. Feb 1996;97(2):707-9. [Medline].

  19. Hide DW, Guyer BM. Cows milk intolerance in Isle of Wight infants. Br J Clin Pract. Sep 1983;37(9):285-7. [Medline].

  20. Hide DW, Matthews S, Matthews L, et al. Effect of allergen avoidance in infancy on allergic manifestations at age two years. J Allergy Clin Immunol. May 1994;93(5):842-6. [Medline].

  21. Horan RF, Sheffer AL. Food-dependent exercise-induced anaphylaxis. Immunol Allergy Clin North Am. 1991;757.

  22. Host A, Halken S. A prospective study of cow milk allergy in Danish infants during the first 3 years of life. Clinical course in relation to clinical and immunological type of hypersensitivity reaction. Allergy. Nov 1990;45(8):587-96. [Medline].

  23. Hourihane JO, Roberts SA, Warner JO. Resolution of peanut allergy: case-control study [see comments]. BMJ. Apr 25 1998;316(7140):1271-5. [Medline].

  24. James JM. Adverse reactions to foods. In: Ziegler EE, Filer LJ, eds. Present Knowledge in Nutrition. 7th ed. Washington, DC: International Life Sciences Institute; 1996:. 604-11.

  25. James JM, Bernhisel-Broadbent J, Sampson HA. Respiratory reactions provoked by double-blind food challenges in children. Am J Respir Crit Care Med. Jan 1994;149(1):59-64. [Medline].

  26. James JM, Burks AW. Food-associated gastrointestinal disease. Curr Opin Pediatr. Oct 1996;8(5):471-5. [Medline].

  27. James JM, Burks AW. Foods. Immunol Clin North Am. 1995;15:477.

  28. James JM, Burks AW, Roberson PK, Sampson HA. Safe administration of the measles vaccine to children allergic to eggs. N Engl J Med. May 11 1995;332(19):1262-6. [Medline].

  29. James JM, Eigenmann PA, Eggleston PA, Sampson HA. Airway reactivity changes in asthmatic patients undergoing blinded food challenges. Am J Respir Crit Care Med. Feb 1996;153(2):597-603. [Medline].

  30. James JM, Sampson HA. An overview of food hypersensitivity. Ped Allergy Immunol. 1992;3:67.

  31. James JM, Zeiger RS, Lester MR, et al. Safe administration of influenza vaccine to patients with egg allergy. J Pediatr. Nov 1998;133(5):624-8. [Medline].

  32. Jansen JJ, Kardinaal AF, Huijbers G, et al. Prevalence of food allergy and intolerance in the adult Dutch population. J Allergy Clin Immunol. Feb 1994;93(2):446-56. [Medline].

  33. Jones SM, Magnolfi CF, Cooke SK, Sampson HA. Immunologic cross-reactivity among cereal grains and grasses in children with food hypersensitivity. J Allergy Clin Immunol. Sep 1995;96(3):341-51. [Medline].

  34. Kelly KJ, Lazenby AJ, Rowe PC, et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology. Nov 1995;109(5):1503-12. [Medline].

  35. Lee CM, Changchien CS, Chen PC, et al. Eosinophilic gastroenteritis: 10 years experience. Am J Gastroenterol. Jan 1993;88(1):70-4. [Medline].

  36. Lever R, MacDonald C, Waugh P, Aitchison T. Randomised controlled trial of advice on an egg exclusion diet in young children with atopic eczema and sensitivity to eggs. Pediatr Allergy Immunol. Feb 1998;9(1):13-9. [Medline].

  37. Ma S, Sicherer SH, Nowak-Wegrzyn A. A survey on the management of pollen-food allergy syndrome in allergy practices. J Allergy Clin Immunol. Oct 2003;112(4):784-8. [Medline].

  38. Nelson HS, Lahr J, Rule R, et al. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol. Jun 1997;99(6 Pt 1):744-51. [Medline].

  39. Odze RD, Wershil BK, Leichtner AM, Antonioli DA. Allergic colitis in infants. J Pediatr. Feb 1995;126(2):163-70. [Medline].

  40. Ortolani C, Ispano M, Pastorello E, et al. The oral allergy syndrome. Ann Allergy. Dec 1988;61(6 Pt 2):47-52. [Medline].

  41. Ortolani C, Ispano M, Pastorello EA, et al. Comparison of results of skin prick tests (with fresh foods and commercial food extracts) and RAST in 100 patients with oral allergy syndrome. J Allergy Clin Immunol. Mar 1989;83(3):683-90. [Medline].

  42. Pastorello EA, Stocchi L, Pravettoni V, et al. Role of the elimination diet in adults with food allergy. J Allergy Clin Immunol. Oct 1989;84(4 Pt 1):475-83. [Medline].

  43. Powell GK. Food protein-induced enterocolitis of infancy: differential diagnosis and management. Compr Ther. Feb 1986;12(2):28-37. [Medline].

  44. Powell GK. Milk- and soy-induced enterocolitis of infancy. Clinical features and standardization of challenge. J Pediatr. Oct 1978;93(4):553-60. [Medline].

  45. Pumphrey RS, Stanworth SJ. The clinical spectrum of anaphylaxis in north-west England. Clin Exp Allergy. Dec 1996;26(12):1364-70. [Medline].

  46. Roberts G, Patel N, Levi-Schaffer F, et al. Food allergy as a risk factor for life-threatening asthma in childhood: a case-controlled study. J Allergy Clin Immunol. Jul 2003;112(1):168-74. [Medline].

  47. Roesler TA, Barry PC, Bock SA. Factitious food allergy and failure to thrive. Arch Pediatr Adolesc Med. Nov 1994;148(11):1150-5. [Medline].

  48. Romano A, Di Fonso M, Giuffreda F, et al. Diagnostic work-up for food-dependent, exercise-induced anaphylaxis. Allergy. Oct 1995;50(10):817-24. [Medline].

  49. Sampson HA. Differential diagnosis in adverse reactions to foods. J Allergy Clin Immunol. Jul 1986;78(1 Pt 2):212-9. [Medline].

  50. Sampson HA. Fatal food-induced anaphylaxis. Allergy. 1998;53(46 Suppl):125-30. [Medline].

  51. Sampson HA. Food allergy. JAMA. Dec 10 1997;278(22):1888-94. [Medline].

  52. Sampson HA. Food allergy. Part 1: immunopathogenesis and clinical disorders. J Allergy Clin Immunol. May 1999;103(5 Pt 1):717-28. [Medline].

  53. Sampson HA. Food allergy. Part 2: diagnosis and management. J Allergy Clin Immunol. Jun 1999;103(6):981-9. [Medline].

  54. Sampson HA. Food-induced anaphylaxis. Novartis Found Symp. 2004;257:161-71; discussion 171-6, 207-10, 276-85. [Medline].

  55. Sampson HA, Ho DG. Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents. J Allergy Clin Immunol. Oct 1997;100(4):444-51. [Medline].

  56. Sampson HA, McCaskill CC. Food hypersensitivity and atopic dermatitis: evaluation of 113 patients. J Pediatr. Nov 1985;107(5):669-75. [Medline].

  57. Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med. Aug 6 1992;327(6):380-4. [Medline].

  58. Sampson HA, Scanlon SM. Natural history of food hypersensitivity in children with atopic dermatitis. J Pediatr. Jul 1989;115(1):23-7. [Medline].

  59. Sicherer SH, Burks AW, Sampson HA. Clinical features of acute allergic reactions to peanut and tree nuts in children. Pediatrics. Jul 1998;102(1):e6. [Medline].

  60. Sicherer SH, Eigenmann PA, Sampson HA. Clinical features of food protein-induced enterocolitis syndrome. J Pediatr. Aug 1998;133(2):214-9. [Medline].

  61. Sicherer SH, Sampson HA. 9. Food allergy. J Allergy Clin Immunol. Feb 2006;117(2 Suppl Mini-Primer):S470-5. [Medline].

  62. Sicherer SH, Sampson HA. The role of food allergy in childhood asthma. Immunol Clin North Am. 1998;18:49-60.

  63. Sigurs N, Hattevig G, Kjellman B. Maternal avoidance of eggs, cow's milk, and fish during lactation: effect on allergic manifestations, skin-prick tests, and specific IgE antibodies in children at age 4 years. Pediatrics. Apr 1992;89(4 Pt 2):735-9. [Medline].

  64. Simons FE. First-aid treatment of anaphylaxis to food: focus on epinephrine. J Allergy Clin Immunol. May 2004;113(5):837-44. [Medline].

  65. Simons FE. First-aid treatment of anaphylaxis to food: focus on epinephrine. J Allergy Clin Immunol. May 2004;113(5):837-44. [Medline].

  66. Sloan AE, Powers ME. A perspective on popular perceptions of adverse reactions to foods. J Allergy Clin Immunol. Jul 1986;78(1 Pt 2):127-33. [Medline].

  67. Spector SL, Nicklas RA. Practice Parameters for the Diagnosis and Treatment of Asthma. J Allergy Clin Immunol. 1996;707.

  68. Steinman HA. "Hidden" allergens in foods. J Allergy Clin Immunol. Aug 1996;98(2):241-50. [Medline].

  69. Weber RW. Food additives and allergy. Ann Allergy. Mar 1993;70(3):183-90. [Medline].

  70. Yocum MW, Butterfield JH, Klein JS, et al. Epidemiology of anaphylaxis in Olmsted County: A population-based study. J Allergy Clin Immunol. Aug 1999;104(2 Pt 1):452-6. [Medline].

  71. Young E, Stoneham MD, Petruckevitch A, et al. A population study of food intolerance. Lancet. May 7 1994;343(8906):1127-30. [Medline].

  72. Yunginger JW, Sweeney KG, Sturner WQ, et al. Fatal food-induced anaphylaxis. JAMA. Sep 9 1988;260(10):1450-2. [Medline].

  73. Zeiger RS, Heller S. The development and prediction of atopy in high-risk children: follow- up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance. J Allergy Clin Immunol. Jun 1995;95(6):1179-90. [Medline].

Further Reading

Keywords

adverse immunologic reactions to foods, allergic reactions to foods, food hypersensitivity, food intolerance, adverse food reactions, lactose intolerance, bacterial food poisoning, peanut allergy, protein-induced enterocolitis syndrome, food hypersensitivity, allergen exposure, anaphylactic reactions, food-induced anaphylactic reaction, oral allergy syndrome, dietary protein enterocolitis, food-induced asthma, food-induced pulmonary hemosiderosis, Heiner syndrome, egg allergy, milk allergy, peanut allergy, soy allergy, fish allergy, shellfish allergy, tree nut allergy, wheat allergy

Contributor Information and Disclosures

Author

Dan Atkins, MD, Assistant Professor, Department of Pediatrics, Division of Ambulatory Pediatrics, Department of Pediatrics, Director, University of Colorado Health Sciences Center; Head, Pediatric Day Program, National Jewish Medical and Research Center
Dan Atkins, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology and American Thoracic Society
Disclosure: Nothing to disclose.

Coauthor(s)

John M James, MD, Department of Allergy and Immunology, Department of Pediatrics, Consulting Staff, Colorado Allergy and Asthma Centers, PC
John M James, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Allergy Asthma and Immunology, American Academy of Pediatrics, American College of Allergy, Asthma and Immunology, American Medical Association, Colorado Medical Society, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Medical Editor

Richard F Lockey, MD, Joy McCann Culverhouse Chair of Allergy and Immunology, Pediatrics and Public Health, James A Haley Veterans' Hospital, Director, Division of Allergy and Immunology, Professor of Medicine, University of South Florida College of Medicine
Richard F Lockey, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American College of Chest Physicians, American College of Physicians, American Medical Association, and Florida Medical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Stephen C Dreskin, MD, PhD, Director of Allergy, Asthma, and Immunology Practice, Departments of Internal Medicine and Immunology, Division of Allergy and, Professor of Medicine, University of Colorado Health Sciences Center
Stephen C Dreskin, MD, PhD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American Association for the Advancement of Science, American Association of Immunologists, American Association of Neuropathologists, American Association of Ophthalmic Pathologists, American Association of Oral and Maxillofacial Surgeons, American College of Allergy, Asthma and Immunology, Clinical Immunology Society, and Joint Council of Allergy, Asthma and Immunology
Disclosure: Nothing to disclose.

CME Editor

Timothy D Rice, MD, Departments of Internal Medicine and Pediatrics and Adolescent Medicine, Associate Professor, Saint Louis University School of Medicine
Timothy D Rice, MD is a member of the following medical societies: American Academy of Pediatrics and American College of Physicians
Disclosure: Nothing to disclose.

Chief Editor

Michael A Kaliner, MD, Clinical Professor of Medicine, Section of Allergy and Immunology, Washington Hospital Center, George Washington University School of Medicine; Chief, Medical Director, Institute for Asthma and Allergy
Michael A Kaliner, MD is a member of the following medical societies: Association of American Physicians
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.